577 related articles for article (PubMed ID: 17626761)
1. [Comparison of the characteristics in recurrence and metastasis between bronchioloalveolar carcinoma and other lung adenocarcinomas].
Zhong XJ; Li DT; Li XL; Mu DB; Zhang XG; Luo JY
Ai Zheng; 2007 Jul; 26(7):785-9. PubMed ID: 17626761
[TBL] [Abstract][Full Text] [Related]
2. Bronchioloalveolar carcinoma of the lung 3 centimeters or less in diameter: a prognostic assessment.
Sakurai H; Dobashi Y; Mizutani E; Matsubara H; Suzuki S; Takano K; Shindo S; Matsumoto M
Ann Thorac Surg; 2004 Nov; 78(5):1728-33. PubMed ID: 15511463
[TBL] [Abstract][Full Text] [Related]
3. Bronchioloalveolar carcinoma of the lung: recurrences and survival in patients with stage I disease.
Breathnach OS; Kwiatkowski DJ; Finkelstein DM; Godleski J; Sugarbaker DJ; Johnson BE; Mentzer S
J Thorac Cardiovasc Surg; 2001 Jan; 121(1):42-7. PubMed ID: 11135158
[TBL] [Abstract][Full Text] [Related]
4. Tissue inhibitor of metalloproteinase 1 is an independent predictor of prognosis in patients with nonsmall cell lung carcinoma who undergo resection with curative intent.
Gouyer V; Conti M; Devos P; Zerimech F; Copin MC; Créme E; Wurtz A; Porte H; Huet G
Cancer; 2005 Apr; 103(8):1676-84. PubMed ID: 15754326
[TBL] [Abstract][Full Text] [Related]
5. [Expressions of Nm23, E-cadherin, and beta-catenin in non-small cell lung cancer and their correlations with metastasis and prognosis].
Tang XJ; Zhou QH; Zhang SF; Liu LX
Ai Zheng; 2005 May; 24(5):616-21. PubMed ID: 15890109
[TBL] [Abstract][Full Text] [Related]
6. Micropapillary pattern: a distinct pathological marker to subclassify tumours with a significantly poor prognosis within small peripheral lung adenocarcinoma (Makimoto Y; Nabeshima K; Iwasaki H; Miyoshi T; Enatsu S; Shiraishi T; Iwasaki A; Shirakusa T; Kikuchi M
Histopathology; 2005 Jun; 46(6):677-84. PubMed ID: 15910599
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor receptor signaling in adenocarcinomas with bronchioloalveolar components.
Sarkaria IS; Zakowski MF; Pham D; Hezel M; Ebright MI; Chuai S; Venkatraman ES; Kris MG; Rusch VW; Singh B
Ann Thorac Surg; 2008 Jan; 85(1):216-23. PubMed ID: 18154814
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological and molecular evidence indicating the independence of bronchioloalveolar components from other subtypes of human peripheral lung adenocarcinoma.
Koga T; Hashimoto S; Sugio K; Yoshino I; Mojtahedzadeh S; Matsuo Y; Yonemitsu Y; Sugimachi K; Sueishi K
Clin Cancer Res; 2001 Jun; 7(6):1730-8. PubMed ID: 11410513
[TBL] [Abstract][Full Text] [Related]
9. [Bronchioloalveolar carcinoma: a retrospective analysis of 52 patients].
Yu H; Wu Y; Rong T
Zhonghua Zhong Liu Za Zhi; 2001 Jul; 23(4):344-6. PubMed ID: 11783124
[TBL] [Abstract][Full Text] [Related]
10. Expression of E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin in bronchioloalveolar carcinoma and conventional pulmonary adenocarcinoma: an immunohistochemical study.
Hidaka N; Nagao T; Asoh A; Kondo Y; Nagao K
Mod Pathol; 1998 Nov; 11(11):1039-45. PubMed ID: 9831199
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of E-cadherin and type IV collagenase genes predicts outcome in patients with stage I non-small cell lung carcinoma.
Herbst RS; Yano S; Kuniyasu H; Khuri FR; Bucana CD; Guo F; Liu D; Kemp B; Lee JJ; Hong WK; Fidler IJ
Clin Cancer Res; 2000 Mar; 6(3):790-7. PubMed ID: 10741698
[TBL] [Abstract][Full Text] [Related]
12. Tissue MMP-2 and MMP-9 [corrected] are better prognostic factors than serum MMP-2/TIMP-2--complex or TIMP-1 [corrected] in stage [corrected] I-III lung carcinoma.
Hoikkala S; Pääkkö P; Soini Y; Mäkitaro R; Kinnula V; Turpeenniemi-Hujanen T
Cancer Lett; 2006 May; 236(1):125-32. PubMed ID: 15982804
[TBL] [Abstract][Full Text] [Related]
13. Detection of early invasion on the basis of basement membrane destruction in small adenocarcinomas of the lung and its clinical implications.
Goto K; Yokose T; Kodama T; Nagai K; Nishiwaki Y; Ando M; Mukai K; Ochiai A
Mod Pathol; 2001 Dec; 14(12):1237-45. PubMed ID: 11743046
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of a histologic subtype in small adenocarcinoma of the lung: the impact of nonbronchioloalveolar carcinoma components.
Sakao Y; Miyamoto H; Sakuraba M; Oh T; Shiomi K; Sonobe S; Izumi H
Ann Thorac Surg; 2007 Jan; 83(1):209-14. PubMed ID: 17184664
[TBL] [Abstract][Full Text] [Related]
15. Poor results after surgery for bronchioloalveolar carcinoma.
Damhuis RA; Schütte PR; Varin OC; van den Berg PM; Heinhuis R; Plaisier PW
Eur J Surg Oncol; 2006 Jun; 32(5):573-6. PubMed ID: 16580808
[TBL] [Abstract][Full Text] [Related]
16. Tumour growth rate and its relationship to prognosis in bronchiolo-alveolar and pulmonary adenocarcinoma.
Heikkilä L; Mattila P; Harjula A; Suomalainen RJ; Mattila S
Ann Chir Gynaecol; 1985; 74(5):210-4. PubMed ID: 3002226
[TBL] [Abstract][Full Text] [Related]
17. Gelatinase B expression as a prognostic factor in patients with stage II/III rectal carcinoma treated by postoperative adjuvant therapy.
Unsal D; Akyurek N; Uner A; Erpolat OP; Han U; Akmansu M; Mentes BB; Dursun A
Am J Clin Oncol; 2008 Feb; 31(1):55-63. PubMed ID: 18376229
[TBL] [Abstract][Full Text] [Related]
18. Results of surgical treatment in bronchioloalveolar carcinoma.
Heikkilä L
Ann Chir Gynaecol; 1986; 75(4):183-91. PubMed ID: 3022637
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary transplantation for advanced bronchioloalveolar carcinoma.
Zorn GL; McGiffin DC; Young KR; Alexander CB; Weill D; Kirklin JK
J Thorac Cardiovasc Surg; 2003 Jan; 125(1):45-8. PubMed ID: 12538984
[TBL] [Abstract][Full Text] [Related]
20. Expression of matrix metalloproteinases in invasive pulmonary adenocarcinoma with bronchioloalveolar component and atypical adenomatous hyperplasia.
Kumaki F; Matsui K; Kawai T; Ozeki Y; Yu ZX; Ferrans VJ; Travis WD
Am J Pathol; 2001 Dec; 159(6):2125-35. PubMed ID: 11733363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
